“They put an IV in your arm, and the first medicine that goes through puts you to sleep. And the second one stops all body functions,” Hendrix said. “They have some kind of button on the IV. You have ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

Patients with vs without rheumatoid arthritis (RA), especially those with RA-associated interstitial lung disease (RA-ILD), have a significantly higher risk of developing lung cancer, according to ...

Scientists are now able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the lungs. In a new study, using a ventilator-on-a-chip model, researchers ...

For the first time, scientists are able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the lungs.

For the first time, scientists are able to directly compare the different kinds of injury that mechanical ventilation causes ...

A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

The following is a summary of “Evaluating sensitization-associated, neuropathic-like symptoms and psychological factors in ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

The route of abatacept administration does not appear to impact its efficacy when treating rheumatoid arthritis-associated interstitial lung disease. The route of abatacept (ABA) administration does ...

Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...